Lenvatinib mesylate is under clinical development by Eisai and currently in Phase I for Epithelial Ovarian Cancer.

Vemurafenib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Thyroid Cancer.

Union Home Minister Amit Shah on Wednesday accused the Congress of twisting and distorting his comments in the Rajya Sabha with regard to Constitution framer Bhimrao Ambedkar, attributing it to ...

Russia has announced a new anti-cancer vaccine, expected to be available by early 2025. This vaccine, developed by leading Russian research centres, aims to stop tumour growth and prevent cancer ...

The country has drawn a false equivalence with Northern Ireland and Palestine. By Finn McRedmond Ireland was the last country in the European Union to host an Israeli embassy. It is now, nearly 30 ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

Copyright 2025 The Associated Press. All Rights Reserved. A police officer stands guard as a health worker administers a polio vaccine to a child, in Peshawar ...

Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor ...

Everolimus (EVE) is the only FDA-approved mTOR inhibitor, which can be used for oral treatment. It effectively inhibits tumor cell proliferation and angiogenesis. It has been administered for various ...

When Luigi Mangione was arrested in the killing of the chief executive of UnitedHealthcare, he was hailed in many corners of the internet as an anti-capitalist folk hero. In a document said to be ...

The New York Times did not publish an article with that headline, spokesperson Brian Latu told USA TODAY. The newspaper also said in an X post that it is a fabrication. The screenshotted image in ...